| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 926 | 2018 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 723 | 2017 |
| Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism MO Johnson, MM Wolf, MZ Madden, G Andrejeva, A Sugiura, ... Cell 175 (7), 1780-1795. e19, 2018 | 619 | 2018 |
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma I Comino-Méndez, FJ Gracia-Aznárez, F Schiavi, I Landa, ... Nature genetics 43 (7), 663-667, 2011 | 604 | 2011 |
| Foxp3 and Toll-like receptor signaling balance T reg cell anabolic metabolism for suppression VA Gerriets, RJ Kishton, MO Johnson, S Cohen, PJ Siska, AG Nichols, ... Nature immunology 17 (12), 1459-1466, 2016 | 527 | 2016 |
| Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas LJ Castro-Vega, A Buffet, AA De Cubas, A Cascón, M Menara, E Khalifa, ... Human molecular genetics 23 (9), 2440-2446, 2014 | 425 | 2014 |
| MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma N Burnichon, A Cascón, F Schiavi, NP Morales, I Comino-Méndez, ... Clinical cancer research 18 (10), 2828-2837, 2012 | 379 | 2012 |
| Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma CC Smith, KE Beckermann, DS Bortone, AA De Cubas, LM Bixby, SJ Lee, ... The Journal of clinical investigation 128 (11), 4804-4820, 2019 | 269 | 2019 |
| AMPK is essential to balance glycolysis and mitochondrial metabolism to control T-ALL cell stress and survival RJ Kishton, CE Barnes, AG Nichols, S Cohen, VA Gerriets, PJ Siska, ... Cell metabolism 23 (4), 649-662, 2016 | 250 | 2016 |
| Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene A Cascón, I Comino-Méndez, M Currás-Freixes, AA de Cubas, ... JNCI: Journal of the National Cancer Institute 107 (5), 2015 | 249 | 2015 |
| Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas E López-Jiménez, G Gómez-López, LJ Leandro-García, I Muñoz, ... Molecular endocrinology 24 (12), 2382-2391, 2010 | 232 | 2010 |
| Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis I Comino-Méndez, AA de Cubas, C Bernal, C Álvarez-Escolá, ... Human molecular genetics 22 (11), 2169-2176, 2013 | 194 | 2013 |
| Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis AA de Cubas, C Bernal, C Sánchez-Malo, S Pedrinaci, E Rapizzi, ... HUMAN MOLECULAR GENETICS 22 (11), 2169-2176, 2013 | 194 | 2013 |
| Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma A Panda, AA de Cubas, M Stein, G Riedlinger, J Kra, T Mayer, CC Smith, ... JCI insight 3 (16), 2018 | 161 | 2018 |
| Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency S Richter, M Peitzsch, E Rapizzi, JW Lenders, N Qin, AA De Cubas, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), 3903-3911, 2014 | 152 | 2014 |
| Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC‐associated factor X N Qin, AA De Cubas, R Garcia‐Martin, S Richter, M Peitzsch, ... International journal of cancer 135 (9), 2054-2064, 2014 | 96 | 2014 |
| Epigenetic modifiers: activities in renal cell carcinoma AA de Cubas, WK Rathmell Nature Reviews Urology 15 (10), 599, 2018 | 95 | 2018 |
| DNA methylation profiling of well‐differentiated thyroid cancer uncovers markers of recurrence free survival V Mancikova, R Buj, E Castelblanco, L Inglada‐Pérez, A Diez, ... International journal of cancer 135 (3), 598-610, 2014 | 88 | 2014 |
| Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy LJ Leandro-García, S Leskelä, C Jara, H Gréen, E Åvall-Lundqvist, ... Clinical Cancer Research 18 (16), 4441-4448, 2012 | 79 | 2012 |
| High frequency and founder effect of the CYP3A4* 20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme M Apellániz-Ruiz, L Inglada-Pérez, MEG Naranjo, L Sánchez, ... The pharmacogenomics journal 15 (3), 288-292, 2015 | 76 | 2015 |
